FDA Adverse Event Injury Summary report: N

MINICAP

MDR report key: 3902749 · Received June 30, 2014

Report

Report Number
1416980-2014-20866
Event Type
Injury
Date Received
June 30, 2014
Date of Event
June 3, 2014
Report Date
June 5, 2014
Manufacturer
BAXTER HEALTHCARE - CLEVELAND
Product Code
KDI
PMA / PMN Number
K895631
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). A REVIEW OF ALL BATCH RECORD DOCUMENTS WAS PERFORMED FOR POTENTIALLY ASSOCIATED LOT NUMBERS GD896597 AND GD896589 WITH NO ISSUES NOTED DURING THE MANUFACTURING PROCESS. THERE WERE NO DEVIATIONS FROM STANDARD PROCEDURE AND NO EXCEPTIONS RELATED TO THE REPORTED CONDITION WERE NOTED. THE DEVICE WAS NOT RETURNED; THEREFORE, A DEVICE ANALYSIS COULD NOT BE COMPLETED. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT A PATIENT EXPERIENCED PERITONITIS MANIFESTED BY ABDOMINAL PAIN COINCIDENT WITH PERITONEAL DIALYSIS (PD) THERAPY, AND WAS HOSPITALIZED THE SAME DAY. THE CAUSE OF THE PERITONITIS WAS UNKNOWN. ON THE DAY OF ONSET, THE PATIENT WAS TREATED WITH VANCOMYCIN INTRAPERITONEALLY (DOSAGE AND FREQUENCY NOT REPORTED) FOR THE PERITONITIS. TREATMENT WITH VANCOMYCIN WAS REPORTED TO BE COMPLETE AFTER 23 DAYS OF PRESCRIBED TREATMENT. THE PATIENT WAS DISCHARGED FROM THE HOSPITAL AFTER TWO DAYS. IT WAS REPORTED THAT THE PATIENT WAS RECOVERING FROM THE PERITONITIS EVENT. DIANEAL THERAPIES WERE ONGOING. ADDITIONAL INFORMATION WAS REQUESTED BUT IS NOT AVAILABLE. THIS IS REPORT 2 OF 4.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
379827 MINICAP DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM KDI BAXTER HEALTHCARE - CLEVELAND

Patients

Seq Age Sex Outcome Treatment
1 52 YR Hospitalization| R EXTENSION SET, MINICAP TRANSFER SET, CASSETTE| HOMECHOICE| DIANEAL 2.5% AND 4.25% PD4 AMBUFLEX| DIANEAL 2.5% AND 4.25% ULTRABAG